Poxel SA (France) Analysis

Poxel Stock Analysis Notes

About 23.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.9. Poxel SA had not issued any dividends in recent years. Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 33 people. To find out more about Poxel SA contact MBA PharmD at 33 4 37 37 20 10 or learn more at https://www.poxelpharma.com.

Poxel SA Investment Alerts

Poxel Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Poxel SA's market, we take the total number of its shares issued and multiply it by Poxel SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 26th of November, Poxel SA holds the Variance of 20.44, coefficient of variation of (352.78), and Risk Adjusted Performance of (0.21). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Poxel SA, as well as the relationship between them.

Poxel SA Price Movement Analysis

Poxel SA Outstanding Bonds

Poxel SA Predictive Daily Indicators

Poxel SA Forecast Models

Poxel SA's time-series forecasting models are one of many Poxel SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Poxel SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Poxel SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Poxel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Poxel SA. By using and applying Poxel Stock analysis, traders can create a robust methodology for identifying Poxel entry and exit points for their positions.

When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.